Synthesis, characterization and theranostic evaluation of Indium-111 labeled multifunctional superparamagnetic iron oxide nanoparticles

Nuclear Medicine and Biology

Volumn 42, Issue 2, 2015, Pages 164-170

  Zolata, Hamidreza ^a   Abbasi Davani, Fereydoun ^b   Afarideh, Hossein ^a  

^a AMIRKABIR UNIVERSITY OF TECHNOLOGY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY   (Iran)

Author keywords

Doxorubicin; Indium 111; SPECT MR imaging; Superparamagnetic iron oxide nanoparticles; Trastuzumab

Indexed keywords

3 AMINOPROPYLTRIETHOXYSILANE; 3,6,9,15 TETRAAZABICYCLO[9.3.1]PENTADECA 1(15),11,13 TRIENE 3,6,9 TRIACETIC ACID; ACETIC ACID DERIVATIVE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HYDRAZONE DERIVATIVE; INDIUM 111; MACROGOL; MALEIMIDE; MALONIC ACID DERIVATIVE; MONOETHYL MALONATE; N HYDROXYSUCCINIMIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TRASTUZUMAB; UNCLASSIFIED DRUG; AMINO-PROPYL-TRIETHOXYSILANE; FERRIC ION; FERRIC OXIDE; INDIUM; MACROGOL DERIVATIVE; MONOCLONAL ANTIBODY; N-HYDROXYSUCCINIMIDE; NANOPARTICLE; SILANE DERIVATIVE; SUCCINIMIDE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CHEMICAL BOND; CHEMICAL MODIFICATION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DECOMPOSITION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DISTRIBUTION; DRUG SYNTHESIS; DRUG TARGETING; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; ISOTOPE LABELING; MOLECULAR IMAGING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PH; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR LOCALIZATION; TUMOR VOLUME; ANIMAL; CHEMISTRY; DIAGNOSTIC USE; DRUG RELEASE; SYNTHESIS; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; CELL LINE, TUMOR; CHEMISTRY TECHNIQUES, SYNTHETIC; DOXORUBICIN; DRUG LIBERATION; FERRIC COMPOUNDS; HUMANS; INDIUM RADIOISOTOPES; ISOTOPE LABELING; MAGNETIC RESONANCE IMAGING; MICE; NANOPARTICLES; POLYETHYLENE GLYCOLS; SILANES; SUCCINIMIDES; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84921313670     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2014.09.007     Document Type: Article

References (30)

1. Loudos G., Kagadis G.C., Psimadas D. Current status and future perspectives of in vivo small animal imaging using radiolabeled nanoparticles. Eur J Radiol 2011, 78:287-295.
2. Koo O., Rubinstein I., Onyuksel H. Role of nanotechnology in targeted drug delivery and imaging: a concise review. J Nanomedicine 2005, 1(3):193-212.
3. Chen T., Cheng T., Chen C., Hsu S.C., et al. Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI. J Biol Inorg Chem 2009, 14:253-260.
4. Kalambur V., Longmire E., Bischof J.C. Cellular level loading and heating of superparamagnetic iron oxide nanoparticles. J Langmuir 2007, 23:12329-12336.
5. Li Z., Tan B., Allix M., Cooper A., Rosseinsky M. direct coprecipitation route to monodisperse dual-functionalized magnetic iron oxide nanocrystals without size selection. J Small 2008, 4:231-239.
6. Schellenberger E., Schnorr J., Reutelingsperger C., et al. Linking proteins with anionic nanoparticles via protamine: ultrasmall protein-coupled probes for magnetic resonance imaging of apoptosis. J Small 2008, 4:225-230.
7. Sun C., Veiseh O., Gunn J., Fang C., et al. In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. J Small 2008, 4:240-249.
8. Brannon-Peppas L., James O. Blanchette. Nanoparticle and targeted systems for cancer therapy. J Adv Drug Deliv Rev 2012, 64:206-212.
9. Grobmyer S., Zhou G., Luke G., et al. Nanoparticle delivery for metastatic breast cancer. J Maturitas 2012, 73:19-26.
10. Garcia-Bennett A., Nees M., Fadeel B. In search of the holy grail: folate-targeted nanoparticles for cancer therapy. J Biochem Pharmacol 2011, 81:976-984.
11. Liu X., Tao H., Yang K., Zhang S., Lee S., Liu Z. Optimization of surface chemistry on single-walled carbon nanotubes for in vivo photothermal ablation of tumors. Biomaterials 2011, 32:144-151.
12. Prencipe G., Tabakman S., Welsher K., et al. PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation. J Am Chem Soc 2009, 131:4783-4787.
13. Liu X.W., Tao H.Q., Yang K., Zhang S., et al. PEGylated FePt@Fe2O3 core-shell magnetic nanoparticles: potential theranostic applications and in vivo toxicity studies. J Nanomed Nanotechnol Biol Med 2013, 9:1077-1088.
14. Fulda S., Debatin K.M. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. J Oncog 2006, 25:4798-4811.
15. Rihova B., Etrych T., Pechar M., et al. Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes. J Control Release 2001, 74:225-232.
16. Ulbrich K., Etrych T., Chytil P., Pechar M., et al. Polymeric anticancer drugs with pH-controlled activation. Int J Pharm 2004, 277:63-72.
17. Itoa A., Kugaa Y., Hondaa H., Kikkawab H., et al. Magnetite nanoparticle-loaded anti-her2 immunoliposomes for combination of antibody therapy with hyperthermia. J Cancer Lett 2004, 212(2):167-175.
18. Zolata H.R., Afarideh H., Abbasi-Davani F. Radio immunoconjugated, Dox-loaded, surface-modified superparamagnetic iron oxide nanoparticles (SPIONs) as a bioprobe for breast cancer tumor theranostics. J Radioanal Nucl Chem 2014, 301:451-460.
19. Misri R., Meier D., Yung A., Kozlowski P., et al. Development and evaluation of a dual-modality (MRI/SPECT) molecular imaging bioprobe. J Nanomed Nanotechnol Biol Med 2012, 8:1007-1016.
20. Heidari Majd M., Asgari D., Barar J., et al. Tamoxifen loaded folic acid armed PEGylated magnetic nanoparticles for targeted imaging and therapy of cancer. J Colloids Surf B Biointerfaces 2013, 106:117-125.
21. Yang X., Hong H., Grailer J.J., et al. RGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and SPECT/MR imaging. Biomaterials 2011, 32:4151-4160.
22. Xu Z., Shen C., Hou Y., et al. Oleylamine as both reducing agent and stabilizer in a facile synthesis of magnetite nanoparticles. J Chem Mater 2009, 21:1778-1780.
23. Xie J., Xu C., Xu Z., Hou Y., et al. Linking hydrophilic macromolecules to monodisperse magnetite (Fe3O4) nanoparticles via trichloro- s-triazine. J Chem Mater 2006, 18:5401-5403.
24. Feng B., Hong R.Y., Wang L.S., Guo L., et al. Synthesis of Fe3O4/APTES/PEG diacid functionalized magnetic nanoparticles for MR imaging. J Colloids Surf A Physicochim Eng Aspects 2008, 328(1-3):52-59.
25. Xiao Y., Hong H., Matson V.Z., et al. Gold nanorods conjugated with doxorubicin and cRGD for combined anti-cancer drug delivery and PET imaging. J Theranostics 2012, 2(8):757-768.
26. Yousefpour P., Atyabi F., Vasheghani-Farahani E., et al. Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab. Int J Nanomedicine 2011, 6:1977-1990.
27. Steinhauser I., Spänkuch B., Strebhardt K., Langer K. Trastuzumab-modified nanoparticles: optimisation of preparation and uptake in cancer cells. J Biomater 2006, 27(28):4975-4983.
28. Weber C., Reiss S., Langer K. Preparation of surface modified protein nanoparticles by introduction of sulfhydryl groups. Int J Pharm 2000, 211(1-2):67-78.
29. Germershaus O., Merdan T., Bakowsky U. Trastuzumab-polyethylenimine-polyethylene glycol conjugates for targeting Her2-expressing tumors. Bioconjug Chem 2006, 17:1190-1199.
30. Debotton N., Zer H., Parnes M. A quantitative evaluation of the molecular binding affinity between a monoclonal antibody conjugated to a nanoparticle and an antigen by surface plasmon resonance. Eur J Pharm Biopharm 2010, 74(2):148-156.